Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study

NCT02196701 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Adalimumab
DRUG: Methotrexate

Sponsor

AbbVie